Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
NCT06767514
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Clinical Study Site Chandler, Arizona, United States
- Clinical Study Site Phoenix, Arizona, United States
- Clinical Study Site Hot Springs, Arkansas, United States
- Clinical Study Sites Jonesboro, Arkansas, United States